These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31389144)

  • 1. A Nanobody-Conjugated DNA Nanoplatform for Targeted Platinum-Drug Delivery.
    Wu T; Liu J; Liu M; Liu S; Zhao S; Tian R; Wei D; Liu Y; Zhao Y; Xiao H; Ding B
    Angew Chem Int Ed Engl; 2019 Oct; 58(40):14224-14228. PubMed ID: 31389144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design and characterization of a novel beta-casein nano-vehicle loaded with platinum anticancer drug for drug delivery.
    Divsalar A; Razmi M; Saboury AA; Seyedarabi A
    Anticancer Agents Med Chem; 2014; 14(6):892-900. PubMed ID: 24521150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
    Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
    Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
    Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
    Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z
    Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR-targeting peptide-coupled platinum(IV) complexes.
    Mayr J; Hager S; Koblmüller B; Klose MHM; Holste K; Fischer B; Pelivan K; Berger W; Heffeter P; Kowol CR; Keppler BK
    J Biol Inorg Chem; 2017 Jun; 22(4):591-603. PubMed ID: 28405842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustered nanobody-drug conjugates for targeted cancer therapy.
    Wu T; Liu M; Huang H; Sheng Y; Xiao H; Liu Y
    Chem Commun (Camb); 2020 Aug; 56(65):9344-9347. PubMed ID: 32672289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells.
    Shoshan MS; Vonderach T; Hattendorf B; Wennemers H
    Angew Chem Int Ed Engl; 2019 Apr; 58(15):4901-4905. PubMed ID: 30561882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity.
    Satpathy M; Mezencev R; Wang L; McDonald JF
    Sci Rep; 2016 Nov; 6():36518. PubMed ID: 27819259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent.
    Yao X; Tracy CM; Bierbach U
    Inorg Chem; 2019 Jan; 58(1):43-46. PubMed ID: 30543413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
    Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
    Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-selective delivery and activation of platinum-based anticancer agents.
    Ding S; Bierbach U
    Future Med Chem; 2015; 7(7):911-27. PubMed ID: 26061108
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity.
    Mi Q; Ma Y; Gao X; Liu R; Liu P; Mi Y; Fu X; Gao Q
    J Biomol Struct Dyn; 2016 Nov; 34(11):2339-50. PubMed ID: 26524393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of [closo-B12(OH)11NH3]-: a new heterobifunctional dodecaborane scaffold for drug delivery applications.
    Bondarev O; Khan AA; Tu X; Sevryugina YV; Jalisatgi SS; Hawthorne MF
    J Am Chem Soc; 2013 Sep; 135(35):13204-11. PubMed ID: 23919884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and antitumor activities of triazacyclodecane and its platinum (II) complex].
    Zhou SS; Zhang QY; Qin K; Lu CH; Xie FX
    Yao Xue Xue Bao; 2008 May; 43(5):490-4. PubMed ID: 18717336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.
    Chatzisideri T; Thysiadis S; Katsamakas S; Dalezis P; Sigala I; Lazarides T; Nikolakaki E; Trafalis D; Gederaas OA; Lindgren M; Sarli V
    Eur J Med Chem; 2017 Dec; 141():221-231. PubMed ID: 29031069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
    Ma R; Wang Y; Yan L; Ma L; Wang Z; Chan HC; Chiu SK; Chen X; Zhu G
    Chem Commun (Camb); 2015 May; 51(37):7859-62. PubMed ID: 25854514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
    Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
    Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Theory To Reinterpret the Kinetics of Monofunctional Platinum Anticancer Drugs: Stacking Matters.
    Veclani D; Melchior A; Tolazzi M; Cerón-Carrasco JP
    J Am Chem Soc; 2018 Oct; 140(43):14024-14027. PubMed ID: 30185041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photocytotoxic cancer cell-targeting platinum(ii) complexes of glucose-appended curcumin and biotinylated 1,10-phenanthroline.
    Upadhyay A; Gautam S; Ramu V; Kondaiah P; Chakravarty AR
    Dalton Trans; 2019 Dec; 48(47):17556-17565. PubMed ID: 31748772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.